Complete Response Durability After TAR-200 and Nadofaragene Firadenovec in BCG-unresponsive Bladder CIS. Fukushima H, Yoshida S, Yajima S, Hirakawa A, et al. Anticancer Res 2026;46:5729-5735.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fukushima H, Yoshida S, Yajima S, Hirakawa A, et al. Complete Response Durability After TAR-200 and Nadofaragene Firadenovec in BCG-unresponsive Bladder CIS. Anticancer Res 2026;46:5729-5735.
PMID: 42823172